Sequential percutaneous tricuspid and pulmonary valve implantation in a young child operated previously for Ebstein

Ender Odemis1, Irem Yenidogan2, Selim Aydin3

  • 1Pediatric Cardiology, Koc University School of Medicine, Istanbul, Turkey.

Cardiology in the Young
|November 16, 2022
PubMed

Insights

This study demonstrates the successful sequential implantation of two valves in a young child with complex congenital heart disease. These minimally invasive procedures offer a feasible treatment option for severe tricuspid and pulmonary valve insufficiency.

Area of Science:

  • Cardiology
  • Congenital Heart Disease
  • Interventional Cardiology

Background:

  • Ebstein's anomaly and pulmonary stenosis present complex challenges in pediatric cardiac care.
  • Previous surgical interventions like tricuspid ring annuloplasty and transannular outflow patch may not provide long-term solutions.
  • Severe tricuspid and pulmonary valve insufficiency necessitates advanced treatment strategies.

Observation:

  • A young child with Ebstein's anomaly and pulmonary stenosis underwent sequential percutaneous valve implantation.
  • The patient had a history of surgical correction at one year of age.
  • The procedures involved percutaneous tricuspid valve implantation followed by percutaneous pulmonary valve implantation.

Findings:

  • Successful sequential percutaneous implantation of both the tricuspid and pulmonary valves was achieved.
  • This approach demonstrates feasibility in a pediatric patient with complex residual valve disease.
  • Minimally invasive valve replacement offers a viable alternative to re-operation.

Implications:

  • Percutaneous valve implantation is a potential therapeutic option for young patients with severe congenital valve disease.
  • This technique may improve outcomes and reduce the need for repeat open-heart surgeries.
  • Further research is warranted to evaluate the long-term efficacy and safety of sequential percutaneous valve implantation in pediatric populations.